Northern Trust’s Accretive Health AH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-19,235
Closed -$111K 4374
2015
Q1
$111K Buy
+19,235
New +$111K ﹤0.01% 4012
2014
Q4
Sell
-19,848
Closed -$154K 4353
2014
Q3
$154K Buy
+19,848
New +$154K ﹤0.01% 3917
2014
Q2
Sell
-865,538
Closed -$6.92M 4314
2014
Q1
$6.92M Sell
865,538
-58,148
-6% -$515K ﹤0.01% 2350
2013
Q4
$8.46M Buy
923,686
+116,606
+14% +$1M ﹤0.01% 2198
2013
Q3
$7.36M Buy
807,080
+5,026
+0.6% +$50K ﹤0.01% 2236
2013
Q2
$8.67M Buy
+802,054
New +$8.44M ﹤0.01% 2021

Other funds holding AH

Northern Trust's AH Position: Q2 2015 in Review

Northern Trust sold out of Accretive Health (AH) in Q2 2015, closing a stake of 19,235 shares — an estimated $111K sold.

Northern Trust first reported a position in AH in Q2 2013 and held it in 6 quarters. The position peaked at $8.67M in Q2 2013. 6 funds tracked by Wall St. Rank hold AH as of Q2 2015.

  • Northern Trust reported no remaining Accretive Health position as of Q2 2015 after selling out during the quarter.
  • Northern Trust sold 19,235 Accretive Health shares in Q2 2015, an estimated $111K.
  • Northern Trust first reported a position in Accretive Health in Q2 2013 and held it in 6 quarters.
  • Northern Trust's Accretive Health position peaked at $8.67M in Q2 2013.
  • 6 funds tracked by Wall St. Rank held Accretive Health as of Q2 2015.

Based on Northern Trust's 13F filing for Q2 2015, filed 13 Aug 2015.